Jeff Sperinde
11Patents
4h-index
18Co-inventors
53Inventor score
Filing activity: Nov 3, 2005 → Oct 22, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8349574B2 | Methods of determining patient response by measurement of Her-3 | Physics | 29 | Active |
| US7939267B2 | Detection of activation of endothelial cells as surrogate marker for angiogenesis | Emerging Cross-Sectional Technologies | 12 | Expired |
| US8470542B2 | Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 | Physics | 10 | Active |
| US10416162B2 | Her2 diagnostic methods | Physics | 6 | Active |
| US9110066B2 | HER-3 antibodies and methods of use | Physics | 4 | Active |
| US9766242B2 | Methods of determining patient response by measurement of HER-3 and P95 | Physics | 3 | Active |
| US9081019B2 | Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95 | Physics | 3 | Active |
| US10273308B2 | Methods of producing antibodies specific for p95 | Physics | 0 | Active |
| US11401344B2 | Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients | Physics | 0 | Active |
| US11579148B2 | Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients | Physics | 0 | Active |
| US10775382B2 | Methods of determining patient response by measurement of HER-3 | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.